ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Coronavirus

Flu-HIV drug mixture helps treat coronavirus, Thai doctors say

Patient tests negative within 48 hours of receiving the cocktail

Masked travelers pass through an airport in Bangkok. Thailand, a popular destination for Chinese tourists, has confirmed 19 coronavirus cases so far. (Photo by Akira Kodaka) 

BANGKOK -- Thai doctors treating patients with the new coronavirus have seen promising results using HIV and flu medications, Thailand's Ministry of Public Health announced on Sunday.

Doctors at a hospital in Bangkok used a mixture of flu drug oseltamivir and HIV treatments lopinavir and ritonavir on a Chinese woman. The doctors said her condition quickly improved and she tested negative for the virus within 48 hours.

Before the drugs were administered, the 71-year-old tourist had shown no signs of recovery for 10 days, after she was identified as a virus carrier.

Chinese medical personnel have already been using HIV and flu drugs to fight the virus, according to Reuters, but the Thai doctors think the key is to combine them. On Jan. 27, U.S. pharmaceutical company AbbVie said it had received a request from Chinese health authorities for its lopinavir/ritonavir drug Aluvia, and had agreed on a donation as an experimental option.

At least one other patient in Thailand improved with the cocktail treatment, Reuters reported, though officials were saying it is too early to determine whether such drug combinations can be used on anyone with the virus.

Thailand, a popular destination for Chinese tourists, has identified 19 coronavirus cases so far, including a Thai taxi driver.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more